Fucoidan modulates SIRT1 and NLRP3 to alleviate hypertensive retinopathy: in vivo and in vitro insights.

Autor: Li J; Department of Ophthalmology, Second Affiliated Hospital of Dalian Medical University, Dalian, 116023, China., Wang X; Department of Ophthalmology, Second Affiliated Hospital of Dalian Medical University, Dalian, 116023, China., Bai J; Department of Public Health Experimental Teaching Center, Dalian Medical University, Dalian, 116044, China., Wei H; Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, 116023, China., Wang W; Department of Ophthalmology, Second Affiliated Hospital of Dalian Medical University, Dalian, 116023, China., Wang S; Department of Ophthalmology, Second Affiliated Hospital of Dalian Medical University, Dalian, 116023, China. wang.s@dmu.edu.cn.
Jazyk: angličtina
Zdroj: Journal of translational medicine [J Transl Med] 2024 Feb 15; Vol. 22 (1), pp. 155. Date of Electronic Publication: 2024 Feb 15.
DOI: 10.1186/s12967-024-04877-6
Abstrakt: Background: Hypertension influences the inflammatory pathological changes in the retina. The function of the inflammasomes is significant. To see if Sirtuin 1 (SIRT1) regulates angiotensin II (Ang II)-induced hypertensive retinopathy and inflammation by modulating NOD-like receptor thermal protein domain associated protein 3 (NLRP3) inflammasome activation and the potential protective effects of fucoidan (FO) in mouse retinal vascular endothelial cells (mRECs) and mice retina.
Methods: The diagnosis of hypertensive retinopathy was made after three weeks of Ang II infusion (3000 ng/kg/min). One day prior to the commencement of Ang II infusion, the mice were treatment with NLRP3 inhibitor MCC950 (10 mg/kg/day, intraperitoneal injections) or FO (300 mg/kg/day, oral gavage). A blood pressure was recorded. Hematoxylin and eosin (H&E) staining was used to conduct pathological alterations, dihydroethidium bromide (DHE) was utilized to assess oxidative stress damage in the retina, and fluorescence angiography was used to identify vascular disorders in the eye. Using immunohistochemical labeling, NLRP3 expression was found. Reactive protein and mRNA expression levels in mouse retina and cells were assessed using Western blot and real-time quantitative polymerase chain reaction (RT-qPCR).
Results: NLRP3 inflammasome activation and SIRT1 decrease were brought about by Ang II infusion. Retinopathy and dysfunction were lessened by MCC950 target-induced NLRP3 inflammasome activation, while overexpression of SIRT1 had the opposite impact on NLRP3 inflammasome activation, indicating that SIRT1 functions as an upstream regulator of NLRP3 activity. FO may improve SIRT1 expression and decrease NLRP3 activation in retinopathy and dysfunction brought on by Ang II, and the effects were consistent across both in vivo and in vitro models.
Conclusions: SIRT1 adversely regulates the NLRP3 inflammasome pathway, which in turn increases Ang II-induced inflammation and hypertensive retinopathy. FO may mitigate Ang II-induced retinopathy and dysfunction via modulating the expression of SIRT1/NLRP3. This implies practical approaches to the management of hypertensive retinopathy.
(© 2024. The Author(s).)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje